Boehringer Ingelheim and Xencor enter a collaboration agreement

21 February 2012
Antibodies engineered with Xencor’s proprietary Xtend™ technology for increasing antibody half-life...

European Commission approves CAPRELSA® (vandetanib) for patients with advanced medullary thyroid cancer

21 February 2012
Marketing authorisation for CAPRELSA® (vandetanib) granted...

Roche’s Zelboraf receives EU approval

20 February 2012
First and only personalized skin cancer medicine allows people with BRAF V600 mutation-positive metastatic melanoma to live significantly longer...

Plexxikon announces European approval of Zelboraf®

20 February 2012
The European Commission has approved Zelboraf® (vemurafenib)...

Bristol-Myers Squibb Foundation announces grants focused on prevention, diagnosis & care of Hepatitis B and Hepatitis C in Asia

18 February 2012
Three new grants awarded...

Gilead announces data for genotype 1 null responder hepatitis C patients enrolled in ELECTRON study

17 February 2012
Viral relapse seen post treatment with GS-7977 plus ribavirin...

Webinar: New monitoring methods improve compliance, reduce costs

Presented by: Joe Gecsey & Paul Farrell
Join us for presentations from some of the leading experts in the fields of monitoring and compliance and pharmaceutical water and cleanroom facility standards.

Find out more >>

Whitepaper: Autoantibody biomarker panels for improved disease diagnosis

Source: Oxford Gene Technology
Download this free white paper for detailed insight into the advantages of autoantibodies as biomarkers, including a review of the current technology and best practices for identification of sensitive and specific autoantibody biomarkers.